Adtran Networks SE (ADV)
XETRA Stock Exchange · Germany · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 21.80 |
|---|---|
| 52-week range | 21.00 – 23.50 |
| Return, 1 month / 3 months | −0.9% / −5.6% |
| Return, 1 year / 3 years | +3.3% / +14.7% |
| Trend | Below its 200-day average |
| RSI (14) | 49 |
| Volatility (1 year) | 7.4% |
| Worst drawdown (1 year) | -9.0% |
| Average daily value traded | 0.17M EUR |
| Dividend yield | 2.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Adtran Networks SE, formerly known as ADVA Optical Networking, is a German supplier of optical networking and Ethernet access equipment. The company designs and builds optical transport platforms, network synchronization systems and encryption hardware used by telecommunications operators, internet service providers and large enterprises. Its equipment carries data traffic across metro and long-haul networks and supports cloud and mobile backhaul connections. The business is based in Germany and serves customers in many countries through its own sales teams and partner channels.
The shares are listed on the XETRA Stock Exchange in Germany under the code ADV, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Adtran Networks SE (ADV) trades on the XETRA Stock Exchange in Germany. It last closed at EUR 21.80 on 23 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 222 of 701 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 3.3% and over the last three months it fell 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on XETRA Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 60 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.5% | ||
| From 52-week high | -6.8% | ||
| Momentum | 48 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.6% | ||
| 6-month return | -2.6% | ||
| 12-month return, skipping the last month | 4.2% | ||
| Stability (higher is calmer) | 99 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 7.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -9.0% | ||
| Liquidity | 51 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.17M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 27 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.4% | ||
| Years with dividends | 2 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.3% |
|---|---|
| 1 month | −0.9% |
| 3 months | −5.6% |
| 6 months | −2.6% |
| 1 year | +3.3% |
| 3 years | +14.7% |
| 5 years | +94.2% |
Signals
| 50-day / 200-day average | 22.28 / 22.36 |
|---|---|
| Golden / death cross (60 days) | Death, 2 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Jun 2026 | EUR 0.5200 |
| 30 Jun 2025 | EUR 0.5200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on XETRA Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.